These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12870503)

  • 1. Access to essential drugs prevented by pharmaceutical multinationals.
    Dev World Bioeth; 2001 May; 1(1):1-6. PubMed ID: 12870503
    [No Abstract]   [Full Text] [Related]  

  • 2. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 3. Innovation and the WHO's essential medicines list: giving credit where credit is due.
    Wertheimer AI; Santella TM
    Res Social Adm Pharm; 2007 Mar; 3(1):137-44. PubMed ID: 17350562
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: will generic drug stores improve access to essential medicines for the poor in India?
    Kotwani A
    J Public Health Policy; 2010 Jul; 31(2):178-84. PubMed ID: 20535100
    [No Abstract]   [Full Text] [Related]  

  • 5. [Access for all to quality drugs].
    Videau JY
    Med Trop (Mars); 2002; 62(4):396-400. PubMed ID: 12534178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GO License: only part of the solution.
    Batson A; Milstien JB
    Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving access to medicines in poor countries: the role of universities.
    Chokshi DA
    PLoS Med; 2006 Apr; 3(6):e136. PubMed ID: 16608382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No deal in sight on cheap drugs for poor countries.
    Fleck F
    Bull World Health Organ; 2003; 81(4):307-8. PubMed ID: 12764500
    [No Abstract]   [Full Text] [Related]  

  • 9. Access to medicines versus access to treatment: the case of type 1 diabetes.
    Beran D; McCabe A; Yudkin JS
    Bull World Health Organ; 2008 Aug; 86(8):648-9. PubMed ID: 18797626
    [No Abstract]   [Full Text] [Related]  

  • 10. Access denied to essential medicines in developing world.
    Ahmad K
    Lancet Infect Dis; 2002 Dec; 2(12):711. PubMed ID: 12467674
    [No Abstract]   [Full Text] [Related]  

  • 11. EU launches measures to stop diversion of cut-price drugs.
    Fleck F
    Bull World Health Organ; 2003; 81(7):549. PubMed ID: 12973652
    [No Abstract]   [Full Text] [Related]  

  • 12. America's drug problem.
    Philpott S
    Hastings Cent Rep; 2012; 42(4):9-10. PubMed ID: 22777971
    [No Abstract]   [Full Text] [Related]  

  • 13. Reprivatizing pharmaceutical supplies in Africa.
    Turshen M
    J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
    Sykes AO
    Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299
    [No Abstract]   [Full Text] [Related]  

  • 15. India's pharmaceutical industry: hype or high tech take-off?
    Malhotra P; Lofgren H
    Aust Health Rev; 2004 Nov; 28(2):182-93. PubMed ID: 15527398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to essential medications for HIV/AIDS in South Africa.
    Andrews S
    S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
    [No Abstract]   [Full Text] [Related]  

  • 17. [Access of developing countries to essential drugs: a process of equity].
    Campion MD
    Bull Acad Natl Med; 2001; 185(7):1255-66; discussion 1266-9. PubMed ID: 11975322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing global essential medicines norms to improve access to AIDS treatment: lessons from Brazil.
    Nunn A; Fonseca ED; Gruskin S
    Glob Public Health; 2009; 4(2):131-49. PubMed ID: 19333805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World pharmaceutical developments.
    Bale H
    World Hosp Health Serv; 2002; 38(2):1. PubMed ID: 12402745
    [No Abstract]   [Full Text] [Related]  

  • 20. The AIDS response catalysing economic and social transformation: the importance of local pharmaceutical production.
    Sidibé M
    Antivir Ther; 2014; 19 Suppl 3():3-4. PubMed ID: 25310132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.